Back
Genpact Vs. BridgeBio Pharma Industry Stock Comparison
Buy
60
G
Genpact
Last Price:
$44.21
Seasonality Move:
2.42%
Buy
68
BBIO
BridgeBio Pharma
Last Price:
$35.60
Seasonality Move:
4.17%
Buy
68
BridgeBio Pharma (BBIO)
is a Buy
Is BridgeBio Pharma a Buy, Sell or Hold?
-
The current BridgeBio Pharma [BBIO] share price is $35.61. The Score for BBIO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
BBIO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
G Stock Price Chart
BBIO Stock Price Chart
What is BridgeBio Pharma's stock price today?
-
The BridgeBio Pharma share price today is $35.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
G Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 56.09 | Buy |
Chaikin Money Flow: | -981301 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.61 - 44.45) | Buy |
Bollinger Bands (100): | (38.43 - 44.33) | Buy |
BBIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.44 | Buy |
Relative Strength Index (14 RSI): | 79.44 | Buy |
Chaikin Money Flow: | 4334718 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.55 - 30.61) | Buy |
Bollinger Bands (100): | (24.19 - 28.69) | Buy |
G Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.55 | Buy |
20-day SMA: | 43.19 | Buy |
50-day SMA: | 43.89 | Buy |
200-day SMA: | 37.11 | Buy |
8-day EMA: | 43.64 | Buy |
20-day EMA: | 43.56 | Buy |
50-day EMA: | 43.05 | Buy |
200-day EMA: | 39.16 | Buy |
BBIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.16 | Buy |
20-day SMA: | 28.52 | Buy |
50-day SMA: | 26.91 | Buy |
200-day SMA: | 26.67 | Buy |
8-day EMA: | 31.02 | Buy |
20-day EMA: | 29.18 | Buy |
50-day EMA: | 27.63 | Buy |
200-day EMA: | 26.98 | Buy |
Genpact Earnings Growth & G Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.32 per share.
BridgeBio Pharma Earnings Growth & BBIO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.16 per share, and an increase next year of $0.70 per share.
Genpact Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BridgeBio Pharma Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |